Locally made AstraZeneca vaccine wins TGA approval
The Therapeutic Goods Administration has approved the release of locally made AstraZeneca COVID-19 vaccines for use in GP clinics and vaccination hubs.
Australia’s vaccine supply received a major boost overnight with the Therapeutic Goods Administration approving the release of locally made AstraZeneca COVID-19 vaccines for use in GP clinics and state vaccination hubs.
The TGA had been carrying out batch testing on local AstraZeneca doses since it granted provisional approval for the vaccine on Sunday.
The medicines regulator has now authorised the release of 832,000 doses of locally made AstraZeneca vaccine, labelling it safe and effective.
“TGA testing of the vaccine batches in our Canberra laboratories plus review of extensive manufacturing documentation, has ensured that the locally manufactured vaccine has the exactly the same composition and performance as the overseas-manufactured vaccine, the same quality, and is free of contaminants,” the TGA said.
The Australian company CSL has been contracted to locally manufacture 50 million doses of AstraZeneca vaccine.
Locally manufactured doses will now be dispatched to about 1100 GP clinics who are initially administering the vaccine.
Whales and ships are on a deadly collision course
The recovery of some whale species amid massive increases in shipping is creating a new threat for the leviathans – and one that could mean changes to Australian shipping.
Rare fish doing swimmingly
In a breakthrough for one of the nation’s rarest fish, the Maugean skate, scientists report ‘great’ success in breeding the species in captivity, dramatically turning around earlier setbacks.